Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 116 results for "Vivitrol"

Alkermes raises full year forecasts as it prepares new drug launch
Irish Times

Alkermes raises full year forecasts as it prepares new drug la...

Company gears up for new schizophrenia drug Aristada as opioid/alcohol therapy Vivitrol beats expectations Alkermes president Shane Cooke. Photograph: Kate Geraghty/ The Irish Times Dominic Coyle Topics: Business Pharma & MedTech Shane Cooke Fda ... Irish Times, 1 month ago

The Bergand Group, Maryland's Leading Addiction Recovery Partners, Now...

The Bergand Group, with offices in Towson and Bel Air, Maryland, now offers Vivitrol as a medication management option to help reduce opioid and alcohol dependence during treatment. Medication Management at The Bergand Group is always used in ...
 PRWeb2 months ago
NPR

Ravages Of Heroin Addiction Haunt Friends, Families And Whole Towns

A water tower in Marion, Ohio. The city has been gripped by heroin addition. Maddie McGarvey for NPR hide caption i toggle caption Maddie McGarvey for NPR Marion, Ohio, just north of Columbus, used to be an idyllic place to grow up. ...
 NPR6 days ago
[x]  
NPR

Others Look To Md. County's Model To Treat Opiate Addictions

When Washington County saw a dramatic rise in heroin addiction, the health department set up a program that starts inmates who are addicted to opiates on a monthly injection
 NPR1 week ago

Alkermes Posts 2Q 2015 Financial Results

Alkermes reported financial results for the second quarter of 2015. "With the PDUFA date for ARISTADA, our proposed brand name for aripiprazole lauroxil, just a few weeks away, we are in the midst of final launch preparations for this important ...
 4 Traders3 weeks ago Alkermes Plc (ALKS) Releases Quarterly Earnings Results  WKRB News4 weeks ago ALKERMES PLC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations  Pharmacy Choice1 month ago Alkermes' (ALKS) CEO Richard Pops on Q2 2015 Results - Earnings Call Transcript  Seeking Alpha1 month ago
[x]  

Medication and Treatment for Substance Abuse from Renaissance Ranch Outpatient Treatment

Renaissance Ranch Outpatient Treatment offers a unique approach to substance abuse treatment. They integrate medically proven methods with a gospel-centered approach to help patients recover. The programs aim to provide a physical, emotional, ...
 Press Release Ping3 weeks ago Substance Abuse Treatment Market Segment Forecasts up to 2020, Research Reports- TransparencyMarketResearch  ARN1 month ago
[x]  

Brokerages Set Alkermes Plc PT at $67.33 (NASDAQ:ALKS)

Shares of Alkermes Plc (NASDAQ:ALKS) have earned a consensus recommendation of Hold from the fourteen analysts that are currently covering the stock, Analyst Ratings Net reports . Four equities research analysts have rated the stock with a sell ...
 WKRB News1 month ago Brokerages Set Alkermes Plc Target Price at $67.33 (NASDAQ:ALKS)  SleekMoney3 weeks ago Alkermes Plc Price Target Raised to $48.00 at Goldman Sachs (ALKS)  SleekMoney1 month ago Alkermes Plc Receives $69.75 Consensus Target Price from Brokerages (NASDAQ:ALKS)  SleekMoney2 months ago

Alkermes Plc's Buy Rating Reiterated at JPMorgan Chase & Co. (ALKS)

JPMorgan Chase & Co. reaffirmed their buy rating on shares of Alkermes Plc (NASDAQ:ALKS) in a report published onThursday, AnalystRatingsNetwork.com reports. They currently have a $77.00 target price on the stock. In other Alkermes Plc news, COO ...
 WKRB News4 weeks ago Alkermes Plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (ALKS)  SleekMoney4 weeks ago Alkermes Plc Given Buy Rating at Cowen and Company (ALKS)  WKRB News1 month ago

Alkermes Plc Downgraded to Sell at Zacks (ALKS)

Zacks reduced shares of Alkermes Plc (NASDAQ:ALKS) from a hold rating to a sell evaluation in a research note released on Friday morning, AnalystRatingsNetwork.com reports. According to Zacks, Alkermes reported more extensive than anticipated ...
 SleekMoney4 weeks ago Alkermes Plc Downgraded by Zacks to Sell (ALKS)  SleekMoney1 month ago Alkermes Plc Lowered to Sell at Zacks (ALKS)  SleekMoney1 month ago

Alkermes' Reports Wider Q2 Loss, Increases Guidance

Alkermes ( ALKS - Analyst Report ) reported a loss (including share-based compensation expense) of 24 cents per share in the second quarter of 2015 wider than the Zacks Consensus Estimate of a loss of 22 cents and the loss of 1 cent in the year ...
 Zacks.com4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less